Le Lézard
Classified in: Health
Subject: MAT

Cheef Botanicals Launches New Line of CBD Hemp Flower


LOS ANGELES, Dec. 11, 2019 /PRNewswire-PRWeb/ -- Cheef Botanicals, a leading CBD manufacturer, today announced a new line of Premium CBD Hemp Flower, which includes popular strains such as Lifter and Hawaiian Haze. The line of hemp flower fills a gap in the manufacturer's offering that meets growing consumer demand. The popularity of CBD flower has been growing year over year, as consumers are learning about legal forms of the cannabis plant.

"To this day, there is confusion about the cannabis flower and the difference between hemp and marijuana. Per the 2018 Farm Bill, hemp flower is now federally legal and contains high levels of CBD, with extremely low amounts of THC. Because of this, cannabis users can now legally consume hemp flower and enjoy the benefits of CBD without becoming intoxicated," says Dareh Zadoorian, Owner of Cheef Botanicals. "After months of careful research, we have partnered with premium hemp farms in Oregon that cultivate plants using strict growing standards."

The premium CBD hemp flower is currently available in two strains and two sizes, based on consumer preference:

The CBD flowers are currently available on the Cheef Botanicals website, CheefBotanicals.com, and will begin shipping to retailers this month. The new line expands Cheef Botanicals' offering of CBD products to also include flower. All products are lab tested by a third party to ensure that purity and quality standards are met, and THC levels are under 0.3%. For more information on CBD hemp flower, visit Cheef Botanicals.

 

SOURCE Cheef Botanicals


These press releases may also interest you

at 07:15
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
Edwards Lifesciences plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To...

at 07:15
GenSight Biologics Announces the Filing of its 2023 Universal Registration Document
Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system...

at 07:15
NeoGenomics Announces Senior Leadership Promotions
NeoGenomics, Inc. , a leading oncology testing services company, today announced two promotions within its senior leadership team, effective immediately. Warren Stone has been promoted to Chief Commercial Officer and will lead NeoGenomics' clinical...

at 07:15
101 Mobility Introduces The Royce Barnhardt Excellence Award at Annual Conference
At its recent Annual Conference, 101 Mobility, a leader in mobility and accessibility solutions, proudly introduced the Royce Barnhardt Excellence Award. This prestigious award is named in honor of Royce Barnhardt, the father of the company's...

at 07:13
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Calliditas Therapeutics AB ("Calliditas"), today announced additional data analyses from the 2-year Phase 3 NeflgArd trial evaluating Nefecon (TARPEYO® (budesonide) delayed-release capsules/Kinpeygo®) in patients with IgA nephropathy (IgAN), were...

at 07:13
HealthPrevent360: An Innovative Approach to Prevention Launches in Washington Heights, Bronx with HDR Healthcare clinics
In a significant leap towards combating health inequities and improving community health, HDR Healthcare Network is proud to implement the HealthPrevent360 program, a comprehensive healthcare solution designed to transform the landscape of preventive...

More news about Health...


News published on and distributed by: